Experimental medicine stage one supports academic researchers conducting human intervention studies to understand disease mechanisms and identify paths towards future treatments or diagnostics.
Experimental medicine: invited stage two application supports academic teams testing disease mechanisms through human interventions to generate insights that could inform future therapies or diagnostics.
UKRI translation: MRC proof of concept: stage two supports academic teams developing and testing medical interventions from prototypes through early clinical trials to advance patient benefit or commercialisation.
MRC: research grant: applicant-led supports research teams pursuing discovery and early translational studies to understand human health and disease and advance diagnosis, treatment and prevention.
Experimental medicine to define mechanisms of gambling disorder: stage one supports academic teams testing causal mechanisms in humans to inform gambling disorder prevention, treatment and policy.
UKRI Translation: MRC Impact Acceleration Awards support academic teams to test one high-risk step in medical intervention development, generating evidence to guide onward development or patient benefit.